Mitsubishi Chemical Group (4188) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Sales revenue for the first half of FY2024 rose 4.3% year-over-year to ¥2,242.1 billion, with core operating income up 44.2% to ¥172.4 billion, driven by strong MMA market, display demand, and improved price management.
Net income attributable to owners fell 39.1% year-over-year to ¥40.9 billion due to structural reform expenses and special items.
New management implemented structural reforms, including downsizing coke furnace, transferring affiliates in carbon business, and transferring triacetate business in specialty materials.
Display-related sales remained strong, semiconductor-related sales showed moderate recovery, but automotive and food-related markets were sluggish.
Comprehensive income plunged to ¥14.1 billion from ¥248.9 billion a year earlier, mainly due to negative foreign currency translation effects.
Financial highlights
Gross profit increased to ¥642.7 billion from ¥562.4 billion year-over-year, while basic EPS declined to ¥28.76 from ¥47.25.
Free cash flow was positive ¥129.8 billion; net interest-bearing debt decreased by ¥112.5 billion.
EBITDA margin rose to 13.8% in 1H FY2024 from 10.8% in FY2023.
Net cash provided by operating activities rose to ¥275.1 billion from ¥195.7 billion year-over-year; net cash used in investing activities increased to ¥145.3 billion.
Net cash used in financing activities was ¥124.0 billion, compared to a net inflow of ¥6.5 billion in the prior year.
Outlook and guidance
Full-year FY2024 core operating income forecast raised 16% to ¥290.0 billion, despite expected 3% lower sales revenue.
Net income forecast for FY2024 remains at ¥52.0 billion, with anticipated losses from structural reforms in the second half.
Annual dividend forecast unchanged at ¥32 per share.
Downward revision in sales and operating income reflects expected demand declines in Specialty Materials and Basic Materials & Polymers in H2, but robust H1 performance supports higher full-year core operating income.
2H performance expected to lag initial forecast, especially in Specialty Materials and Basic Materials & Polymers, due to weaker display and semiconductor demand and intensified competition.
Latest events from Mitsubishi Chemical Group
- Profits fell on restructuring and impairments, but FY2026 rebound is forecast, led by Specialty Materials.4188
Q4 20268 Jul 2026 - Revenue and core operating income rose, but net income fell on special losses; portfolio reforms ongoing.4188
Q3 20258 Jul 2026 - FY26 strategy targets growth in specialty materials, semiconductors, and composites, driven by reforms and investments.4188
Investor presentation25 May 2026 - Net income surged on asset sales, but profit guidance was cut due to restructuring losses.4188
Q3 202613 Apr 2026 - Sales and core operating income surged, but net income fell; major structural reforms underway.4188
Q1 20252 Feb 2026 - Core operating income up 43%, net income down 62%, with major portfolio reforms and Pharma divestiture.4188
Q4 202518 Nov 2025 - Specialty materials and semiconductors outperformed as profits fell; full-year outlook steady.4188
Q1 202616 Nov 2025 - Net income soared on one-time gains, but MMA weakness and restructuring weighed on results.4188
Q2 20262 Nov 2025